Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SRPT

Recent news which mentions SRPT

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Sarepta Therapeutics To Rally Over 53%? Here Are 10 Other Analyst Forecasts For Wednesday
Tickers AAP AMBA BLDR HPQ
Tags AAP TWKS News
From Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Tickers AMC BILI BMR BRSP
Tags Benzinga PSHG LION
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers BGS BMR BRSP CBIO
Tags SRPT Market News YANG
From InvestorPlace
Sarepta Therapeutics (SRPT) Q4 2022 Earnings Call Transcript
Tickers SRPT
Tags Recent Press Releases SRPT Market News
From Motley Fool
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
Tickers BIIB EWTX RETA SPX
Tags BIIB SPX RETA
From MarketWatch
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tickers BLPH CBIO CPHI CUTR
Tags BZI/TFM SXTC Benzinga
From Benzinga
Earnings Scheduled For February 28, 2023
Tickers NFE NNI NRDY NSTG
Tags TGTX OCN PRFT
From Benzinga
Expert Ratings for Sarepta Therapeutics
Tickers SRPT
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
3 Gene Editing Stocks With the Best Long-Term Potential
Tickers CRSP GNOM MYGN NTLA
Tags Market News CRSP SRPT
From InvestorPlace
9 Analysts Have This to Say About Sarepta Therapeutics
Tickers SRPT
Tags SRPT Benzinga Market News
From Benzinga
7 Biotech Stocks That Will Make You Rich in 10 Years
Tickers ABBV CRSP CVAC DIS
Tags CVAC NYSE:ABBV,NYSE:DIS,NYSE:PFE,NASDAQ:INCY,NASDAQ:EXEL,NASDAQ:CRSP,NASDAQ:VRTX,NASDAQ:SRPT,NASDAQ:CVAC Stocks to Buy
From InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2023
Tickers CRSP SRPT VRTX
Tags Market News CRSP Recent Press Releases
From Motley Fool
BTIG Maintains Buy Rating for Sarepta Therapeutics: Here's What You Need To Know
Tickers SRPT
Tags SRPT Benzinga BZI/AAR/UPDATE
From Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
Tickers AZN GH SRPT
Tags GH Recent Press Releases SRPT
From Motley Fool
Analyst Ratings for Sarepta Therapeutics
Tickers SRPT
Tags SRPT Benzinga Analyst Ratings
From Benzinga
Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
Tickers SRPT
Tags Recent Press Releases SRPT Market News
From Motley Fool
Earnings Scheduled For November 2, 2022
Tickers QMCO QRVO RACE RARE
Tags Z THRM SMG
From Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
Tickers DNA NVCR SRPT
Tags Recent Press Releases SRPT NVCR
From Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2022
Tickers CRSP SRPT
Tags SRPT Recent Press Releases CRSP
From Motley Fool
Apple To $177? Plus This Analyst Slashes PT On Opendoor Technologies By About 71%
Tickers AAPL BILL LIN OPEN
Tags Benzinga Analyst Ratings LIN
From Benzinga
7 Analysts Have This to Say About Sarepta Therapeutics
Tickers SRPT
Tags Benzinga SRPT BZI/AAR
From Benzinga
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
Tickers PEPG SRPT
Tags Reiteration Price Target PEPG
From Benzinga
$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
Tickers CNA COIN SRPT
Tags CNA News Trading Ideas
From Benzinga
Analyst Ratings for Sarepta Therapeutics
Tickers SRPT
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
Tickers SRPT
Tags Health Care Analyst Color Trading Ideas
From Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
Tickers SRPT
Tags General News Benzinga
From Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
Tickers CRSP MYGN SRPT
Tags Market News CRSP MYGN
From Motley Fool
Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
Tickers SRPT
Tags Trading Ideas News Health Care
From Benzinga
Is Biotech Back? This Analyst Sees 18% Upside Potential In This Bio Play
Tickers SRPT
Tags Media Benzinga Analyst Ratings
From Benzinga
Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts
Tickers SRPT
Tags Analyst Ratings News General
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.